BTIG analyst Mark Massaro lowered the price target on Personalis (NASDAQ: PSNL) to $7.00 (from $8.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence DetectionMarch 3, 2025 6:00 AM Personalis (PSNL) PT Lowered to $7 at NeedhamFebruary 28, 2025 7:39 AM Form S-8 Personalis, Inc. February 27, 2025 5:27 PM Form S-3 Personalis, Inc. February 27, 2025 5:26 PM Form 10-K Personalis, Inc. For: Dec 31February 27, 2025 5:11 PM Personalis, Inc. (PSNL) Tops Q4 EPS by 6cFebruary 27, 2025 4:14 PM Form 8-K Personalis, Inc. For: Feb 27February 27, 2025 4:07 PM Personalis Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 27, 2025 4:01 PM